SPOTLIGHT: Levaquin approval expanded

SPOTLIGHT ON... Levaquin approval expanded
Johnson & Johnson's short-course antibiotic Levaquin got the FDA's approval as a treatment for stubborn urinary-tract infections and kidney infection. Release

Suggested Articles

Trump has said the coronavirus outbreak doesn't pose a major threat to the U.S., but the White House is weighing naming a "czar," Politico…

After a major label expansion in December, Amarin's Vascepa is preparing a major boom in sales with its marketing team nearly scaled up.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.